@prefix : <http://purl.org/nanopub/temp/mynanopub#> .
@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

:provenance {
    :assertion prov:generatedAtTime "2021-07-12T10:50:10.272178"^^xsd:dateTime .
}

:pubInfo {
    : prov:generatedAtTime "2021-07-12T10:50:10.272178"^^xsd:dateTime ;
        prov:wasAttributedTo <https://orcid.org/1234-1234-1234-1234> .
}

:assertion {
    :association a rdf:Statement ;
        rdf:object <http://purl.obolibrary.org/obo/MONDO_0002009> ;
        rdf:predicate biolink:treats ;
        rdf:subject <https://identifiers.org/DRUGBANK:DB00193> ;
        biolink:description "Tramadol was reported to be an effective or very effective antidepressant by 94.6% of patients (123/130) who provided ratings submitted to User Reviews for Tramadol to Treat Depression. Tramadol addiction has been reported in individuals who have consumed high doses for prolonged periods. " ;
        biolink:has_population_context :context ;
        biolink:provided_by <https://w3id.org/um/NeuroDKG> ;
        biolink:publications <https://pubmed.ncbi.nlm.nih.gov/33344902> ;
        biolink:relation <https://w3id.org/um/neurodkg/OffLabelIndication> .

    <http://purl.obolibrary.org/obo/MONDO_0002009> a biolink:Disease ;
        rdfs:label "Major depressive disorder" .

    :context a biolink:Cohort ;
        rdfs:label "Adults" .

    <https://identifiers.org/DRUGBANK:DB00193> a biolink:Drug ;
        rdfs:label "Tramadol" .
}

:Head {
    : a np:Nanopublication ;
        np:hasAssertion :assertion ;
        np:hasProvenance :provenance ;
        np:hasPublicationInfo :pubInfo .
}

